CombiMatrix Value Stock - Dividend - Research Selection
Fundamental data and company key figures of the share
|Annual reports in|
|Net operating cash flow|
|Free cash flow|
|Liabilities & Shareholders equity|
|Diluted shares outstanding|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Raw Data Source|
Description of the company
CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary CombiMatrix Molecular Diagnostics, Inc., based in Irvine, California. The company operates as a diagnostic reference laboratory that offers DNA-assisted clinical diagnostic testing to physicians, hospitals, clinics and other laboratories in the field of pre- and post-natal developmental disorders as well as hematology / oncology genomics. The company's BAC arrays enable the company to conduct aCGH studies to assess genomic changes. The company's oligo arrays enable the company to execute aCGH on a much finer scale than BAC technology can. For the year ended December 31, 2011, the Company also owns a 33% interest in Leuchemix, Inc. (Leuchemix), a privately-held drug development company focused on the development of a range of compounds for the treatment of a range of oncologically-related diseases.